| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/13/1993 | WO1993009234A2 Suppressor and progenitor cells |
| 05/13/1993 | WO1993009233A2 Recombinant amyloid precursor protein inhibitor domain and treatment of various disease states |
| 05/13/1993 | WO1993009232A1 NOVEL THROMBIN INHIBITOR PROTEIN FROM $i(REDUVII) |
| 05/13/1993 | WO1993009231A1 Novel thrombin-inhibiting protein from ticks |
| 05/13/1993 | WO1993009230A1 Cellular nucleic acid binding protein and uses thereof in regulating gene expression and in the treatment of aids |
| 05/13/1993 | WO1993009229A1 Recombinant bone morphogenetic protein heterodimers, compositions and methods of use |
| 05/13/1993 | WO1993009228A1 TGF-β TYPE RECEPTOR cDNAS AND USES THEREFOR |
| 05/13/1993 | WO1993009227A1 Human neuropeptide y-y1 receptor |
| 05/13/1993 | WO1993009226A1 Novel endopeptidase and peptide substrate cleaving and inactivating activity thereof |
| 05/13/1993 | WO1993009222A2 Transfection of vertebrate cells e.g. by homologous recombination |
| 05/13/1993 | WO1993009218A1 Modified genes and their expression in plant cells |
| 05/13/1993 | WO1993009144A1 Recombinant core-streptavidin |
| 05/13/1993 | WO1993009143A1 Production and use of multimeric hemoglobins |
| 05/13/1993 | WO1993009142A1 Acute phase proteins for detection and prognosis of infection and tissue damage |
| 05/13/1993 | WO1993009141A1 Antigen associated with type i diabetes mellitus |
| 05/13/1993 | WO1993009140A1 A FAT CELL SPECIFIC β-ADRENERGIC RECEPTOR |
| 05/13/1993 | WO1993009139A1 Production of complementary dna representing hepatitis a viral sequences by recombinant dna methods and uses therefor |
| 05/13/1993 | WO1993009138A1 Isolation and use of spider toxins |
| 05/13/1993 | WO1993009137A1 Inhibitors of collagen-induced platelet aggregation |
| 05/13/1993 | WO1993009136A1 Phosphonopeptides with collagenase inhibiting activity |
| 05/13/1993 | WO1993009135A1 Peptides inhibiting il-1 beta release |
| 05/13/1993 | WO1993009133A1 C8-cyclic peptidomimetics as fibrinogen antagonists |
| 05/13/1993 | WO1993009132A1 Hiv protease inhibitors containing guanidine |
| 05/13/1993 | WO1993009130A1 Materials comprising and methods of preparation and use for ribosome-inactivating proteins |
| 05/13/1993 | WO1993008842A1 Hemoglobins as drug delivery agents |
| 05/13/1993 | WO1993008836A1 Induction of protection against viral infection by synergy between viral proteins and viral peptides |
| 05/13/1993 | WO1993008835A1 Cd8+ cell antiviral factor |
| 05/13/1993 | WO1993008831A1 Expression of recombinant hemoglobin and hemoglobin variants in yeast |
| 05/13/1993 | WO1993008829A1 Compositions that mediate killing of hiv-infected cells |
| 05/13/1993 | WO1993008827A1 Natural killer cell enhancing factor |
| 05/13/1993 | WO1993008826A1 Treating retinal neuronal disorders by the application of insulin-like growth factors and analogs |
| 05/13/1993 | WO1993008824A1 Synthetic lung surfactant having antioxidant properties |
| 05/13/1993 | WO1993008821A1 Side effect inhibitor for cancer therapy |
| 05/13/1993 | WO1993008820A1 Treatment of neurological conditions by an interleukin-1 inhibiting compound |
| 05/13/1993 | WO1993008819A1 Treatment of neurological conditions by an interleukin-1 inhibiting compound |
| 05/13/1993 | WO1993008817A1 Cd8 binding domain peptides |
| 05/13/1993 | WO1993008816A1 Pharmaceutical lysine-containing polypeptide compositions and methods of use thereof |
| 05/13/1993 | WO1993008812A1 Reconstituted platelet membrane vesicles |
| 05/13/1993 | WO1993008701A1 C-myc dna binding partners, motifs, screening assays, and uses thereof |
| 05/13/1993 | WO1993008693A1 Novel coleopteran-active bacillus thuringiensis isolates and genes encoding coleopteran-active toxins |
| 05/13/1993 | WO1993008692A1 Bacillus thuringiensis isolates active against cockroaches and genes encoding cockroach-active toxins |
| 05/13/1993 | WO1993008682A1 A method of obtaining high methionine-containing corn seeds, and uses thereof |
| 05/13/1993 | WO1993005807A3 Erythropoietin potentiating agents and methods for their use |
| 05/13/1993 | WO1993005751A3 Osteogenic proteins in the treatment of bone deseases |
| 05/13/1993 | WO1992021697A3 Diagnostic peptides derived from m.tuberculosis antigens |
| 05/13/1993 | DE4200043A1 Recombinant CD30 antigen (KI-1) and corresp. nucleic acid - for diagnosis of anaplastic large-cell lymphoma, and for prepn. of antibodies and antisera, in immuno-absorption, etc. |
| 05/13/1993 | DE4136513A1 Neues thrombininhibitorisches protein aus raubwanzen Consuming bugs novel thrombin protein from |
| 05/13/1993 | CA2124858A1 Suppressor and progenitor cells |
| 05/13/1993 | CA2122991A1 Transfection of vertebrate cells by homologous recombination |
| 05/13/1993 | CA2122617A1 Myogenic vector systems |
| 05/13/1993 | CA2122491A1 Tgf-.beta. type receptor cdnas and uses therefor |
| 05/13/1993 | CA2122480A1 Reconstituted platelet membrane vesicles |
| 05/13/1993 | CA2122367A1 Nucleotide sequences hybridizing specifically with the mycobacterium avium-intracellulare complex bacterial strains, their use as oligonucleotide primers and nucleotide probes; method for the identification of the mycobacterium avium-intracellulare complex mycobacteria necessary for the... |
| 05/13/1993 | CA2122359A1 Antigen associated with type i diabetes mellitus |
| 05/13/1993 | CA2122266A1 Cd8 binding domain peptides |
| 05/13/1993 | CA2122263A1 Induction of protection against viral infection by synergy between virus envelope glycoprotein and peptides corresponding to neutralization epitopes of the glycoprotein |
| 05/13/1993 | CA2122261A1 Modified genes and their expression in plant cells |
| 05/13/1993 | CA2122147A1 Phosphonepeptides with collagenase inhibiting activity |
| 05/13/1993 | CA2122024A1 Pharmaceutical lysine-containing polypeptide compositions and methods of use thereof |
| 05/13/1993 | CA2121683A1 A method for detecting a differentiation marker in normal and carcinoma cells and in biological samples and body fluid |
| 05/13/1993 | CA2121352A1 Novel thrombin-inhibitory protein from assassin bugs |
| 05/13/1993 | CA2121246A1 Novel thrombin-inhibitory protein from ticks |
| 05/13/1993 | CA2117268A1 Novel coleopteran-active bacillus thuringiensis isolates and genes encoding coleopteran-active toxins |
| 05/13/1993 | CA2117267A1 Bacillus thuringiensis isolates active against cockroaches and genes encoding cockroach-active toxins |
| 05/13/1993 | CA2116653A1 Peptides inhibiting il-1 beta release |
| 05/13/1993 | CA2082748A1 Antithrombotic agents |
| 05/12/1993 | EP0541335A1 Recombinant DNA sequences and plasmids for cellular immunity vaccines from bacterial toxinantigen conjugates |
| 05/12/1993 | EP0541214A2 Use of interleukin-10 analogs or antagonists to treat endotoxin- or superantigen induced toxicity |
| 05/12/1993 | EP0541089A2 cDNA of human hepatitis C virus, its clone and use thereof |
| 05/12/1993 | EP0541058A1 Expression of a mature proteinase 2a, its partial purification and preparation of inhibitory active substrates |
| 05/12/1993 | EP0540969A2 Derivatives of structurally modified VIP and pharmaceutical compositions containing them |
| 05/12/1993 | EP0540719A1 Dictyostelid expression vector and method for expressing a desired protein |
| 05/12/1993 | EP0540709A1 Novel antipathogenic peptides and compositions containing same |
| 05/12/1993 | EP0540687A1 Antibody-mediated cofactor-driven reactions |
| 05/12/1993 | EP0540675A1 Inhibition of mac-1 receptor binding to fibrinogen using d 30? homologs |
| 05/12/1993 | EP0540663A1 Interleukin 8 inhibition of cytokine-induced histamine release from bosophils or mast cells |
| 05/12/1993 | EP0540651A1 Endogenously sweetened transgenic plant products |
| 05/12/1993 | EP0540645A1 Methods of use of bovine respiratory syncytial virus recombinant dna, proteins vaccines, antibodies, and transformed cells |
| 05/12/1993 | EP0540626A1 Process for synthesizing peptides |
| 05/12/1993 | EP0540591A1 Cell necrosis detection through assays for spectrin and breakdown products thereof. |
| 05/12/1993 | EP0540586A1 Binding domains |
| 05/12/1993 | EP0540575A1 Human meg-csf protein and methods |
| 05/12/1993 | EP0540525A1 Method of preparation of vaccines, and the use of the vaccines thus prepared |
| 05/12/1993 | EP0525054A4 Modified heparin binding growth factors |
| 05/12/1993 | EP0217822B1 Human metallothionein-ii promoter in mammalian expression system |
| 05/12/1993 | EP0160670B1 Monoclonal antibodies against endotoxin of gram-negative bacteria |
| 05/12/1993 | CN1071845A Injectable extended release formulations and methods |
| 05/12/1993 | CA2082450A1 Hybrid transforming growth factors |
| 05/11/1993 | US5210185 Preparing active beta subunit by homogenizing human placenta tissue, centrifuging homogenate, recovering supernatant, dialyzing to dissociate 7S NGF form, fractionating by cation exchange chromatography, purifying, polyclonal antibodies |
| 05/11/1993 | US5210183 Protein Arp, with immunoglobulin A binding activity, the corresponding vectors and hosts, reagent kit and pharmaceutical composition |
| 05/11/1993 | US5210182 Acid conditioning |
| 05/11/1993 | US5210181 T-lymphotropic retrovirus peptide |
| 05/11/1993 | US5210180 Nonapeptides |
| 05/11/1993 | US5210075 Interleukin 6 antagonist peptides |
| 05/11/1993 | US5210074 Method for preparing a dried composition of insulin-like growth factor i |
| 05/11/1993 | US5210035 Non-reventing live vaccines |
| 05/11/1993 | US5210032 Producing acetone and butanol |
| 05/11/1993 | US5210028 Process for the production of unfused igf-ii protein in e. coli |
| 05/11/1993 | US5210027 DNA encoding novel antimicrobial polypeptide and methods for obtaining such polypeptide |
| 05/11/1993 | US5210026 Human mk gene and method of expression |